Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Applied Optics|March 16, 2007
Photonic explorers based on multifunctional nanoplatforms for biosensing and photodynamic therapyYong-Eun Lee Koo, Wenzhe Fan, Hoejin Hah, et al.
Analytical Chemistry|September 21, 2010
Near infrared luminescent oxygen nanosensors with nanoparticle matrix tailored sensitivityYong-Eun Koo Lee, Elyse E Ulbrich, Gwangseong Kim, et al.
Oncotarget|June 21, 2015
Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete responseYingqiang Zhang, Wenzhe Fan, Kangshun Zhu, et al.
Annals of Translational Medicine|December 14, 2020
The role of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatitis B virus-related hepatocellular carcinomaLixin Ke, Rui Shen, Wenzhe Fan, et al.
Cancer Research and Treatment|April 2, 2020
Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular CarcinomaMiao Xue, Yanqin Wu, Wenzhe Fan, et al.
Clinical Therapeutics|July 16, 2019
Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective StudyWenzhe Fan, Guosheng Yuan, Huishuang Fan, et al.
Frontiers in Oncology|January 4, 2024
Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombusAoran Dong, Meiyan Zhu, Zeyu Zhang, et al.
Cancer Medicine|June 14, 2022
Idarubicin-Loaded DEB-TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score-matching analysisWenzhe Fan, Bowen Zhu, Shufan Yue, et al.
Frontiers in Immunology|June 27, 2025
Efficacy and safety of TACE combined with lenvatinib and PD-1 Inhibitor in intermediate-stage HCC exceeding the up-7 criteria: a retrospective cohort studyMiao Xue, Yanqin Wu, Yiyang Tang, et al.
Acta Pharmaceutica Sinica. B|March 6, 2023
Anti-PD-L1 antibody enhances curative effect of cryoablation <i>via</i> antibody-dependent cell-mediated cytotoxicity mediating PD-L1<sup>high</sup>CD11b<sup>+</sup> cells elimination in hepatocellular carcinomaJizhou Tan, Ting Liu, Wenzhe Fan, et al.
Pageof 10